Why we’re lowering our Bristol Myers price target despite an earnings beat, guidance raise

Why we’re lowering our Bristol Myers price target despite an earnings beat, guidance raise

Bristol Myers Squibb ‘s earnings beat and rosy outlook Thursday did not resolve lingering issues for the stock. But it was enough, for now. Revenue in the first quarter, which ended March 31, dipped 6% to $11.2 billion but topped estimates of $10.7 billion, according to LSEG. Adjusted earnings per share of $1.80 beat expectations … Read more

Danaher’s quarterly results show signs of life, and the struggling stock soars

Danaher’s quarterly results show signs of life, and the struggling stock soars

Danaher shares on Tuesday climbed more than 6% after the health-care company’s first-quarter results exceeded expectations — and, crucially, its guidance was left mostly intact despite an evolving economic picture. Count us among the investors breathing a sigh of relief. Revenue for the three months ended March 31 declined 1% year over year to $5.74 … Read more

Abbott Labs shares surge on earnings and a big sign of confidence in the business

Abbott Labs shares surge on earnings and a big sign of confidence in the business

Shares of Abbott Laboratories jumped Wednesday after the diversified health-care company delivered strong first-quarter results and left its earnings guidance intact — a big sign of confidence in an uncertain time. Revenue in the three months ended March 31 rose 4% to $10.36 billion, narrowly missing the consensus of $10.4 billion, according to estimates compiled … Read more